ReviewBiological psychiatry2014
A focus on structural brain imaging in the Alzheimer's disease neuroimaging initiative.
Review in Biological psychiatry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed.
- Socio-environmental and health-related factors and their association with longitudinal change in brain neuroimaging markers through the plasma metabolome among UK adults: An additive Bayesian network analysis.Brain, behavior, & immunity - health · 2025Article
- Nicotine Ameliorates α-Synuclein Preformed Fibril-Induced Behavioral Deficits and Pathological Features in Mice.Applied biochemistry and biotechnology · 2025Article
- Associations of plasma von Willebrand Factor levels with cognitive decline and neurodegeneration in older adults without dementia.Frontiers in aging neuroscience · 2025Article
- Association of Motor Function With Cognitive Trajectories and Structural Brain Differences: A Community-Based Cohort Study.Neurology · 2023Article
- Using artificial intelligence to learn optimal regimen plan for Alzheimer's disease.Journal of the American Medical Informatics Association : JAMIA · 2023Article
- Using Artificial Intelligence to Learn Optimal Regimen Plan for Alzheimer's Disease.medRxiv : the preprint server for health sciences · 2023Article
- Pulmonary function is associated with cognitive decline and structural brain differences.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2022Article
- Testing a convolutional neural network-based hippocampal segmentation method in a stroke population.Human brain mapping · 2022Article
- A deep learning toolbox for automatic segmentation of subcortical limbic structures from MRI images.NeuroImage · 2021Article
- Joint cortical surface and structural connectivity analysis of Alzheimer's Disease.Proceedings of SPIE--the International Society for Optical Engineering · 2021Article
- Article
- Do 2-year changes in superior frontal gyrus and global brain atrophy affect cognition?Alzheimer's & dementia (Amsterdam, Netherlands) · 2018Article
- Test-retest reproducibility of [EJNMMI research · 2017Article
- Impact of Demographic and Obstetric Factors on Infant Brain Volumes: A Population Neuroscience Study.Cerebral cortex (New York, N.Y. : 1991) · 2017Article
- Translational MRI Volumetry with NeuroQuant: Effects of Version and Normative Data on Relationships with Memory Performance in Healthy Older Adults and Patients with Mild Cognitive Impairment.Journal of Alzheimer's disease : JAD · 2017Article
- The superior fault tolerance of artificial neural network training with a fault/noise injection-based genetic algorithm.Protein & cell · 2016Article
- Segmentation of human brain using structural MRI.Magma (New York, N.Y.) · 2016Review
- Detection of Alzheimer's disease signature in MR images seven years before conversion to dementia: Toward an early individual prognosis.Human brain mapping · 2015Article
- A novel cortical thickness estimation method based on volumetric Laplace-Beltrami operator and heat kernel.Medical image analysis · 2015Article
- Diffusion weighted imaging-based maximum density path analysis and classification of Alzheimer's disease.Neurobiology of aging · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
In recent years, numerous laboratories and consortia have used neuroimaging to evaluate the risk for and progression of Alzheimer's disease (AD). The Alzheimer's Disease Neuroimaging Initiative is a longitudinal, multicenter study that is evaluating a range of biomarkers for use in diagnosis of AD, prediction of patient outcomes, and clinical trials. These biomarkers include brain metrics derived from magnetic resonance imaging (MRI) and positron emission tomography scans as well as metrics derived from blood and cerebrospinal fluid. We focus on Alzheimer's Disease Neuroimaging Initiative studies published between 2011 and March 2013 for which structural MRI was a major outcome measure. Our main goal was to review key articles offering insights into progression of AD and the relationships of structural MRI measures to cognition and to other biomarkers in AD. In Supplement 1, we also discuss genetic and environmental risk factors for AD and exciting new analysis tools for the efficient evaluation of large-scale structural MRI data sets such as the Alzheimer's Disease Neuroimaging Initiative data.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.